SynBioBeta Speaker
Clayton Rabideau
CEO
Syntensor Incorporated
Clayton is the founder of Syntensor, a startup that develops frontier models for drug development and human genetics with a particular focus on predicting the underlying drivers of clinical trial outcomes and trait prediction from human genomes."
SynBioBeta 2025 - Session Speaker
Reprogramming Biology at Cloud Speed
Biotech is accelerating—and cloud infrastructure is the catalyst. This session explores how scalable compute, AI-native architectures, and real-time data integration are transforming the way biology is engineered. From protein design to genome editing, discover how innovators are leveraging cloud-native platforms to run complex simulations, automate workflows, and shorten the cycle from hypothesis to insight. Hear from leaders building the tools that are making biology programmable, iterative, and as fast as software development.
AI-Driven Breakthroughs: Accelerating Drug Discovery and Genetic Medicine
In an era where AI is transforming medicine, drug discovery and genetic therapies are entering a new frontier. This session will explore how AI accelerates the development of innovative therapies, from optimizing molecular designs to enabling precise, tissue-specific genetic interventions. Discover how cutting-edge AI technologies are advancing therapeutic modalities, enhancing delivery systems, and unlocking the potential of personalized medicine. Join leading experts as they share groundbreaking insights into AI-driven innovation and its profound impact on the future of drug discovery and genetic medicine.
AI-Driven Insights: Predicting Efficacy and Toxicity in Next-Gen Drug Discovery
AI is revolutionizing drug discovery—not just by accelerating timelines, but by enhancing our ability to predict how drugs behave in the body. This session highlights cutting-edge approaches like dynamic systems simulations that model mechanistic interactions at the cellular level. Learn how platforms are able to generating causal hypotheses to forecast both efficacy and toxicity, unlocking smarter, safer therapeutic development.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Meals & Refreshments
Post Event Video Access
Price increases in
08:19:55:11
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
2026
Event Updates